Last reviewed 2026-04-20 · How we verify

E-Z-Hd (BARIUM SULFATE)

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal cramping
• Aspiration pneumonitis
• Barium sulfate impaction
• Intestinal perforation with consequent peritonitis
• Granuloma formation
• Vasovagal episodes
• Syncopal episodes

Key clinical trials

• Effect of 1% Melatonin Gel Versus Calcium Hydroxide as an Intracanal Medicament on the Intensity of Postoperative Pain, Bacterial Load Reduction and Periapical MMP-9 Levels in Patients With Necrotic Pulp. (NA)
• REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy (PHASE2)
• Measuring Apical Debris Extrusion With a Novel Laboratory Technique (NA)
• Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial (PHASE4)
• Changes in Tactile Perception in People With Segmental Exclusion Syndrome
• Precise Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Bleeding: A Randomized Controlled Trial (NA)
• Optimisation and Performance of Reduced Preparation CT Colography (PHASE4)
• Comparison Of Implant Position Achieved With Fully Guided Versus Partially Guided Implant Placement (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• E-Z-Hd CI brief — competitive landscape report
• E-Z-Hd updates RSS · CI watch RSS